课题基金 / 基金详情

EFFICACY AND SAFETY OF TIBOLONE IN POSTMENOPAUSAL WOMEN

EFFICACY AND SAFETY OF TIBOLONE IN POSTMENOPAUSAL WOMEN
替勃龙对绝经后女性的疗效和安全性
批准号：
6118886
负责人：
BRUCE KESSEL
金额：
$3.17万
依托单位：
BETH ISRAEL DEACONESS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/6118886
关键词：
chemoprevention clinical research dosage drug screening /evaluation female hormone therapy human subject human therapy evaluation osteoporosis outcomes research postmenopause progesterone analog skeletal disorder chemotherapy

项目摘要

项目成果

BRUCE KESSEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To determine the minimum effective dose of Tibolone for prevention of menopausal osteoporosis and to demonstrate the efficacy, safety and acceptability of the medication at the therapeutic dose for this indication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFFICACY AND SAFETY OF TIBOLONE IN POSTMENOPAUSAL WOMEN
ANTIOXIDANT POTENTIAL OF ESTROGENS IN MENOPAUSE
INTRAOVARIAN ROLE OF STEROIDS IN GRANULOSA CELL FUNCTION
INTRAOVARIAN ROLE OF STEROIDS IN GRANULOSA CELL FUNCTION
海外基金